Percheron Therapeutics Ltd (ASX:PER) Insider James Garner Acquires 1,500,000 Shares

Percheron Therapeutics Ltd (ASX:PERGet Free Report) insider James Garner purchased 1,500,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 24th. The stock was bought at an average price of A$0.01 ($0.00) per share, for a total transaction of A$10,500.00 ($6,521.74).

James Garner also recently made the following trade(s):

  • On Wednesday, November 27th, James Garner bought 125,000 shares of Percheron Therapeutics stock. The shares were acquired at an average price of A$0.07 ($0.04) per share, with a total value of A$8,875.00 ($5,512.42).
  • On Thursday, November 14th, James Garner purchased 375,000 shares of Percheron Therapeutics stock. The shares were bought at an average cost of A$0.08 ($0.05) per share, for a total transaction of A$30,000.00 ($18,633.54).

Percheron Therapeutics Stock Performance

About Percheron Therapeutics

(Get Free Report)

Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.

Featured Stories

Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.